Several possible studies
Story checked
Ulcerative colitis burden across 7MM to exceed 2.36 million cases by 2035, forecasts GlobalData (opens in a new tab)
news-medical.net · 2026-10-28
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Ulcerative colitis burden across 7MM to exceed 2.36 million cases by 2035, forecasts GlobalData
news-medical.net · 2026-10-28
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedGlobalData projects that diagnosed prevalent ulcerative colitis cases in the seven major markets will exceed 2.36 million by 2035.View evidenceHide evidence
As statedover 2.36 million cases by 2035
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 5Not checkedGlobalData says diagnosed incident ulcerative colitis cases in the 7MM will rise from 190,044 in 2025 to 194,968 in 2035, an annual growth rate of 0.26%.View evidenceHide evidence
As statedfrom 190,044 in 2025 to 194,968 in 2035; AGR 0.26%
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 5Not checkedThe report says the US will have the highest number of diagnosed prevalent UC cases in the 7MM by 2035, while Italy will have the fewest.View evidenceHide evidence
As statedUS approximately 1.03 million; Italy approximately 123,789
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 5Not checkedThe article says most UC cases are diagnosed between ages 15 and 30, and that comorbidities and diet/lifestyle factors contribute to burden and flares.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 5Not checkedGlobalData's report suggests a substantial share of diagnosed prevalent UC in adults is mild, while a greater proportion is TNF-non-responding, and it calls for biomarker-guided therapy and clinical trials for alternative targets.View evidenceHide evidence
As statedapproximately 46% mild UC; approximately 53% TNF-non-responding
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
Real-World Epidemiology of Inflammatory Bowel Disease in Italy: Treatment Patterns, Adherence, and Costs in Patients with Ulcerative Colitis Treated with Mesalazine.
Drugs - Real World Outcomes · 2026 · PubMed
P1242 Incidence of Acute Severe Ulcerative Colitis in a Changing Landscape of Increased Disease Prevalence and More Effective Therapies
Journal of Crohn's and Colitis · 2025 · Crossref
Rising burden of inflammatory Bowel disease in Northeastern Italy: a population-based analysis of prevalence and incidence trends from 2012 to 2024.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026 · PubMed, Europe PMC
The burden of inflammatory bowel disease in Asia (1990-2023) and projections to 2050: A comprehensive analysis of the 2023 global burden of disease study.
PloS One · 2026 · PubMed
Ulcerative Colitis in the Kinneret Sub District, Israel 1965-1994
Journal of Clinical Gastroenterology · 1998 · Crossref